# Congenital Cardiac Surgery * **Definition:** A specialized branch of cardiac surgery that focuses on the surgical treatment of congenital heart defects, which are structural abnormalities of the heart present at birth, involving procedures to repair or correct these defects to improve heart function and overall health. * **Taxonomy:** Specialties / Congenital Cardiac Surgery ## News * Selected news on the topic of **Congenital Cardiac Surgery**, for healthcare technology leaders * 668 news items are in the system for this topic * Posts have been filtered for tech-related keywords | Date | Title | Source | | --- | --- | --- | | 5/27/2025 | [**Clinical asset management industry report highlights major trends reshaping health care in 2025**](https://www.globenewswire.com/news-release/2025/05/27/3088776/0/en/Clinical-asset-management-industry-report-highlights-major-trends-reshaping-health-care-in-2025.html) | [[Globe Newswire]] | | 5/27/2025 | [**Clinical asset management industry report highlights major trends reshaping health care in 2025**](https://www.morningstar.com/news/globe-newswire/9458458/clinical-asset-management-industry-report-highlights-major-trends-reshaping-health-care-in-2025) | [[Morningstar]] | | 5/12/2025 | [**Todd Craig, MD - Vice President, Clinical Informatics - Mercy - LinkedIn**](https://www.linkedin.com/in/todd-m-craig) | [[Linkedin]] | | 5/6/2025 | [**Career Opportunities and Advancements with an MSN Nursing Degree**](https://healthcareguys.com/2025/05/06/career-opportunities-and-advancements-with-an-msn-nursing-degree/?utm_source=rss&utm_medium=rss&utm_campaign=career-opportunities-and-advancements-with-an-msn-nursing-degree) | [[The Healthcare Guys]] | | 5/2/2025 | [**Atropos Further Integrates Into Stanford Health Care's EHR - Healthcare Innovation**](https://www.hcinnovationgroup.com/analytics-ai/big-data/article/55287653/atropos-further-integrates-into-stanford-health-cares-ehr) | [[Healthcare Innovation]] | | 4/8/2025 | [**US Digital Pathology Market worth US$2.01 billion by 2029 with 13.1AGR**](https://www.prnewswire.com/news-releases/us-digital-pathology-market-worth-us2-01-billion-by-2029-with-13-1-cagr--marketsandmarkets-302423082.html) | [[PR Newswire]] | | 4/8/2025 | [**US Digital Pathology Market worth US$2.01 billion by 2029 with 13.1AGR**](https://finance.yahoo.com/news/us-digital-pathology-market-worth-143000008.html) | [[Yahoo Finance]] | | 3/24/2025 | [**Techcyte Unveils Fusion, the First Unified Anatomic and Clinical Digital Pathology Platform**](https://finance.yahoo.com/news/techcyte-unveils-fusion-first-unified-160000930.html) | [[Yahoo Finance]] | | 2/25/2025 | [**5 tips to determine how tech can support your physicians - American Medical Association**](https://www.ama-assn.org/practice-management/digital/5-tips-determine-how-tech-can-support-your-physicians) | [[AMA]] | | 12/12/2024 | [**Structural Heart Devices Market to Hit USD 25.69 Billion by 2029 with 9.5AGR - MarketsandMarkets™**](https://www.prnewswire.com/news-releases/structural-heart-devices-market-to-hit-usd-25-69-billion-by-2029-with-9-5-cagr--marketsandmarkets-302329967.html) | [[PR Newswire]] | | 12/6/2024 | [**Indonesia reports first robotic cardiac surgery and more briefs - Healthcare IT News**](https://www.healthcareitnews.com/news/asia/indonesia-reports-first-robotic-cardiac-surgery-and-more-briefs) | [[Healthcare IT News]] | | 12/5/2024 | [**Study shows impact of experience on outcomes in cardiac septal reduction procedures**](https://medicalxpress.com/news/2024-12-impact-outcomes-cardiac-septal-reduction.html) | [[MedicalXpress]] | | 11/25/2024 | [**HemoSonics Honored as One of the Fastest-Growing Companies in North America ... - Business Wire**](https://www.businesswire.com/news/home/20241125160459/en/HemoSonics-Honored-as-One-of-the-Fastest-Growing-Companies-in-North-America-on-the-2024-Deloitte-Technology-Fast-500) | [[Business Wire]] | | 11/25/2024 | [**HemoSonics Honored as One of the Fastest-Growing Companies in North America on the 2024 Deloitte Technology Fast 500**](http://www.businesswire.com/news/home/20241125160459/en/HemoSonics-Honored-as-One-of-the-Fastest-Growing-Companies-in-North-America-on-the-2024-Deloitte-Technology-Fast-500/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 11/21/2024 | [**New heart bill signals 'changing course' for this subspecialty - Becker's Hospital Review**](https://www.beckershospitalreview.com/cardiology/new-heart-bill-signals-changing-course-for-this-subspecialty.html) | [[Beckers Hospital Review]] | | 10/28/2024 | [**Ultrasonic Scalpel Market to Grow by USD 992 Million from 2024-2028, Driven by Demand for Faster, Safer Surgery and AI Impact on Market Trends - Technavio**](https://www.prnewswire.com/news-releases/ultrasonic-scalpel-market-to-grow-by-usd-992-million-from-2024-2028-driven-by-demand-for-faster-safer-surgery-and-ai-impact-on-market-trends---technavio-302287651.html) | [[PR Newswire]] | | 10/27/2024 | [**Longeveron® Presents Lomecel-B™ Long-term Transplant-free Survival Data in Hypoplastic Left Heart Syndrome (HLHS) at the Congenital Heart Surgeons' Society (CHSS) 51st Annual Meeting**](https://www.globenewswire.com/news-release/2024/10/27/2969739/0/en/Longeveron-Presents-Lomecel-B-Long-term-Transplant-free-Survival-Data-in-Hypoplastic-Left-Heart-Syndrome-HLHS-at-the-Congenital-Heart-Surgeons-Society-CHSS-51st-Annual-Meeting.html) | [[Globe Newswire]] | | 10/3/2024 | [**Etiometry's Automated Clinical Pathways Now Deployed Across All ICU Segments, Enabling Standardized Care and Cost Savings in the Most Complex and Expensive Units**](http://www.businesswire.com/news/home/20241003936011/en/Etiometry%E2%80%99s-Automated-Clinical-Pathways-Now-Deployed-Across-All-ICU-Segments-Enabling-Standardized-Care-and-Cost-Savings-in-the-Most-Complex-and-Expensive-Units/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 9/16/2024 | [**KFSHRC Redefines Global Healthcare with AI and Robotic Surgery Innovations**](https://www.globenewswire.com/news-release/2024/09/16/2946988/0/en/KFSHRC-Redefines-Global-Healthcare-with-AI-and-Robotic-Surgery-Innovations.html) | [[Globe Newswire]] | | 7/30/2024 | [**Orchestra BioMed Announces Appointment of Cardiovascular Device Industry Expert John Mack to Board of Directors**](https://finance.yahoo.com/news/orchestra-biomed-announces-appointment-cardiovascular-120000976.html) | [[Yahoo Finance]] | | 7/23/2024 | [**AtriCure Receives Regulatory Approval to Sell AtriClip® Devices in China**](http://www.businesswire.com/news/home/20240723273609/en/AtriCure-Receives-Regulatory-Approval-to-Sell-AtriClip%C2%AE-Devices-in-China/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 7/18/2024 | [**Health IT Business News - July 18, 2024**](https://www.healthitanswers.net/health-it-business-news-july-18-2024/) | [[Health IT Answers]] | | 7/18/2024 | [**Oxygenators Market Size, Industry Trends, Growth - Report Analysis [2032]**](http://prsync.com/imarc-group/oxygenators-market-size-industry-trends-growth--report-analysis--4211629/) | [[PRSync]] | | 7/9/2024 | [**Surgical Suction Instruments Market: $375M to $503M Growth Forecast (2024-2029) - MarketsandMarkets™**](https://www.globenewswire.com/news-release/2024/07/09/2910332/0/en/Surgical-Suction-Instruments-Market-375M-to-503M-Growth-Forecast-2024-2029-MarketsandMarkets.html) | [[Globe Newswire]] | | 6/4/2024 | [**What Were Reading: Medicaid Expansion for Mental Health; CVD Surge by 2050; MDMA-Based Therapy for PTSD**](https://www.ajmc.com/view/what-we-re-reading-medicaid-expansion-for-mental-health-cvd-surge-by-2050-mdma-based-therapy-for-ptsd) | [[AJMC]] | ## Specialty Overview (Some LLM-derived content — please confirm with above primary sources) ### Key Players - **Boston Children's Hospital**: A premier center for pediatric cardiac surgery, specializing in complex congenital heart defects. - **Children's Hospital of Philadelphia**: A leading institution in pediatric cardiac surgery, known for its innovative approaches and research in congenital heart defects. - **Cleveland Clinic**: Renowned for its heart program, including congenital cardiac surgery, offering advanced surgical techniques and comprehensive care. - **Memorial Cardiac and Vascular Institute**: A leading center for cardiovascular care, specializing in congenital heart disease. - **Children's Hospital of Philadelphia (CHOP)**: A leading institution in pediatric congenital heart surgery, known for its innovative surgical techniques and research. - **Ann & Robert H. Lurie Children's Hospital of Chicago**: Conducting research on prenatal diagnosis of congenital heart defects. - **American Academy of Pediatrics (AAP)**: An organization that has introduced new screening algorithms for congenital heart disease. - **Texas Children's Hospital**: One of the largest pediatric heart transplant programs in the U.S., recognized for its pioneering work in pediatric cardiovascular surgery. - **Phoenix Children's Research Institute**: An institute conducting extensive research on pediatric health, including congenital heart defects. - **UCLA Health**: Researching genetic indicators in children with neurodevelopmental disorders, including congenital heart defects. - **BrightHeart**: A company focused on enhancing AI technology for detecting congenital heart defects during pregnancy. - **Boston Scientific**: A major player in the structural heart devices market, focusing on minimally invasive therapies. - **Rady Children's Hospital-San Diego**: A leading institution in pediatric cardiac care, known for innovative technologies like the Arc Viewer. - **Longeveron Inc.**: A biotechnology company developing therapies for congenital heart disease, particularly Hypoplastic Left Heart Syndrome. - **SS Innovations**: A company specializing in robotic surgical systems, recently achieving milestones in robotic cardiac surgery in Indonesia. - **King Faisal Specialist Hospital & Research Centre (KFSHRC)**: A leader in robotic cardiac surgeries, recognized for high survival rates and innovative procedures. - **PECA Labs**: A company focused on developing innovative cardiovascular devices, recently enhancing its board with experienced cardiac surgeons. ### Partnerships and Collaborations - **Congenital Heart Initiative**: Aimed at addressing the healthcare needs of adults with congenital heart defects, enhancing research and care. - **Research initiatives with universities**: Collaborations with academic institutions to conduct research on congenital heart defects and improve surgical techniques. - **Boston Children's Hospital and Engineering Team**: Collaboration to integrate engineering techniques in cardiac surgery, improving surgical outcomes through CFD modeling. - **Pediatric Cardiology Associates and Tampa Bay Adult Congenital Heart Center**: Joined BayCare Medical Group to enhance pediatric cardiac care in the region. - **Research collaborations**: Institutions like CHOP and Boston Children's Hospital often partner with universities for research on congenital heart defects and surgical outcomes. - **Fabric Genomics and Intermountain Children's Health**: Collaboration to analyze pediatric genomes, improving diagnosis and treatment for congenital heart disease. - **Partnerships with technology firms**: Hospitals are increasingly collaborating with tech companies to develop advanced surgical tools and telemedicine solutions for congenital heart surgery. - **Rivers Health and Hoops Family Children's Hospital**: Collaboration to introduce specialized pediatric cardiology services, addressing congenital heart disease and related disorders. - **Walton Institute**: Collaborating with Science Foundation Ireland and the Irish Research Council to enhance research in congenital heart disease diagnostics. - **SS Innovations and Harapan Kita National Cardiac Hospital**: Partnered to introduce advanced robotic surgical solutions in Indonesia. - **Hoag Healthcare System and SeamlessMD**: Collaborated to reduce patient length of stay and readmissions for cardiac surgery patients. - **BrightHeart and Sofinnova Partners**: Collaboration to develop AI technology for prenatal ultrasound evaluations. - **Dr. Stewart Goldman and 15 children's hospitals**: Leading a trial to evaluate the effectiveness of the Optune device in treating pediatric brain tumors. - **Collaboration between hospitals and technology firms**: Many hospitals are partnering with technology companies to develop advanced surgical tools and simulation technologies for training and pre-operative planning. - **Texas Heart Institute and Baylor College of Medicine**: Announced a five-year partnership to enhance cardiovascular care, combining resources and expertise. - **NHLBI and Longeveron Inc.**: Collaboration for the ongoing ELPIS II trial assessing Lomecel-BTM as an adjunct therapy for HLHS. - **KFSHRC and AI Technologies**: KFSHRC utilizes AI-driven patient management and robotic surgeries to improve healthcare services. - **PECA Labs and Dr. Joseph E. Bavaria**: Dr. Bavaria's appointment to PECA Labs' board aims to enhance the development of innovative cardiovascular devices. - **Trawick International and Cleveland Clinic**: Partnering to provide policyholders access to the clinic's Global Patient Services program. - **MyOme and Novi Health**: Partnership to offer genetic insights and counseling to employees, aiming to enhance preventative care. ### Innovations, Trends, and Initiatives - **Robotic Surgery**: The adoption of robotic-assisted surgical techniques to enhance precision in congenital heart surgeries. - **Congenital Heart Disease Research**: The CDC's National Congenital Heart Disease Research, Surveillance, and Awareness Program aims to improve detection and intervention strategies. - **Computational Fluid Dynamics (CFD)**: Used by Boston Children's Hospital to enhance surgical planning and outcomes for congenital heart disease patients. - **Robotic Cardiac Surgery**: KFSHRC has performed over 400 robotic heart surgeries, showcasing advancements in minimally invasive techniques. - **CoNARTaS Study**: Investigating health outcomes of children born after assisted reproductive technology, highlighting increased risk for congenital heart defects. - **Valve Repair Workflow**: Successfully implemented for 75 patients at Boston Children's Hospital, showcasing the potential of CFD in pediatric cardiac care. - **3D Modeling Workflows**: Implemented by specialized teams at Boston Children's Hospital for timely interventions in pediatric cardiac cases. - **CCHD Screening Algorithm**: AAP's new guidelines emphasize the importance of pulse oximetry screening and standardized data collection for congenital heart disease. - **Teleprehabilitation**: Multimodal personalized teleprehabilitation prior to cardiac surgery significantly reduces major adverse cardiovascular events post-surgery. - **Make Your Medical Device Pitch for Kids!**: A competition supporting the development of pediatric medical devices for congenital heart defects. - **AI in Congenital Heart Disease**: An AI model effectively predicts long-term mortality in individuals with congenital heart disease. - **Stem Cell Research**: Studies showing potential of stem cell-derived heart cells in treating congenital heart defects in monkeys. - **Leadless Pacemaker Technology**: Dan Cortez implanted the first dual chamber leadless pacemaker in a child, representing a significant innovation in pediatric electrophysiology. - **AI in Prenatal Ultrasound**: BrightHeart's AI software aims to improve detection of congenital heart defects during fetal ultrasounds. - **AI in Diagnostics**: Dr. Lizy Abraham's research aims to develop AI algorithms for analyzing phonocardiogram signals to improve congenital heart disease diagnosis. - **Transcatheter Heart Valve Technologies**: Advancements in minimally invasive technologies are driving growth in the structural heart devices market. ### Challenges and Concerns - **Access to Care**: Many patients face barriers to accessing specialized congenital cardiac surgery, particularly in rural or underserved areas. - **Long-term Outcomes**: Ongoing research is needed to understand the long-term outcomes of patients who undergo congenital cardiac surgery, particularly as they transition into adulthood. - **Congenital Heart Defects Prevalence**: Children conceived through assisted reproductive technology have a higher likelihood of developing congenital heart defects. - **Transitioning Care for Adults**: The transition from pediatric to adult care for congenital heart disease patients remains challenging due to a lack of trained healthcare providers. - **Access to Advanced Diagnostics**: The urgent need for improved diagnostic tools for congenital heart diseases in newborns, particularly in underserved areas. - **Healthcare Disparities**: Socioeconomic factors affecting access to prenatal care and timely diagnosis of congenital heart defects. - **Underdiagnosis of Congenital Heart Disease**: Studies indicate that congenital heart disease is often underestimated and underdiagnosed, particularly in high-altitude communities. - **Data Standardization**: The need for uniform data reporting in congenital heart disease screening to assess effectiveness and improve health outcomes. - **Healthcare Access Disparities**: Inadequate healthcare access contributes to the challenges in diagnosing and treating congenital heart disease, especially in women living at high altitudes. - **Long-term Effects of COVID-19**: Clinicians face uncertainty in evaluating and treating long-term effects of COVID-19, which may impact patients with congenital heart disease. - **Healthcare Accessibility**: Efforts to expand pediatric cardiac care services face challenges in ensuring comprehensive access across regions. - **Access to Prenatal Care**: Patients with Medicaid are less likely to receive prenatal diagnoses of heart defects due to socioeconomic barriers. - **Gender Disparities in Cardiac Care**: Research indicates that women may receive care at lower-quality hospitals, leading to higher mortality rates post-surgery. - **Gender Disparities in Cardiac Surgery Outcomes**: Research indicates female patients are more likely to die from postoperative complications compared to male patients. - **Cost of Treatment**: High costs associated with advanced surgical procedures and post-operative care can be a significant burden for families. - **COVID-19 Impact on Cardiac Events**: Severe COVID-19 infections have been linked to major cardiac events, raising concerns for patients with pre-existing conditions. - **Technological Integration**: Integrating new technologies into existing surgical practices can be challenging and requires training and adaptation. - **Quality Metrics Establishment**: Boston Children's Hospital is still in the process of establishing quality metrics for their CFD program. ## Related Topics [[Cardiac Surgery]]